Evidence map›Paper›PMID 23904482›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Neuronal prostaglandin E2 receptor subtype EP3 mediates antinociception during inflammation.

Gabriel Natura, Karl-Jürgen Bär, Annett Eitner, Michael K Boettger, Frank Richter, Susanne Hensellek, Andrea Ebersberger, Johannes Leuchtweis, Takayuki Maruyama, Gunther Olaf Hofmann and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Targeting prostaglandin ENature communications · 2025
    Article
  12. Direct Effects of the Janus Kinase Inhibitor Baricitinib on Sensory Neurons.International journal of molecular sciences · 2024
    Article
  13. Article
  14. PGE2 Potentiates Orai1-Mediated Calcium Entry Contributing to Peripheral Sensitization.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Gabriel NaturaInstitute of Physiology I, Jena University Hospital, Friedrich Schiller University Jena, 07740 Jena, Germany.
Karl-Jürgen Bär
Annett Eitner
Michael K Boettger
Frank Richter
Susanne Hensellek
Andrea Ebersberger
Johannes Leuchtweis
Takayuki Maruyama
Gunther Olaf Hofmann
Karl-Jürgen Halbhuber
Hans-Georg Schaible
Jena University Hospital · DEFriedrich Schiller University Jena · DEOno Pharmaceutical (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pain mediator prostaglandin E2 (PGE2) sensitizes nociceptive pathways through EP2 and EP4 receptors, which are coupled to Gs proteins and increase cAMP. However, PGE2 also activates EP3 receptors, and the major signaling pathway of the EP3 receptor splice variants uses inhibition of cAMP synthesis via Gi proteins. This opposite effect raises the intriguing question of whether the Gi-protein-coupled EP3 receptor may counteract the EP2 and EP4 receptor-mediated pronociceptive effects of PGE2. We found extensive localization of the EP3 receptor in primary sensory neurons and the spinal cord. The selective activation of the EP3 receptor at these sites did not sensitize nociceptive neurons in healthy animals. In contrast, it produced profound analgesia and reduced responses of peripheral and spinal nociceptive neurons to noxious stimuli but only when the joint was inflamed. In isolated dorsal root ganglion neurons, EP3 receptor activation counteracted the sensitizing effect of PGE2, and stimulation of excitatory EP receptors promoted the expression of membrane-associated inhibitory EP3 receptor. We propose, therefore, that the EP3 receptor provides endogenous pain control and that selective activation of EP3 receptors may be a unique approach to reverse inflammatory pain. Importantly, we identified the EP3 receptor in the joint nerves of patients with painful osteoarthritis.

Indexed as

Analysis of VarianceAnimalsDNA PrimersHumansImmunohistochemistryInflammationJointsNociceptionNociceptorsOsteoarthritisPatch-Clamp TechniquesPolymerase Chain ReactionPolymorphism, Restriction Fragment LengthRatsRats, Inbred LewReceptors, Prostaglandin E, EP3 SubtypeDNA PrimersReceptors, Prostaglandin E, EP3 Subtypemechanical hyperalgesiasodium currents

Identifiers

PMID23904482
PMCPMC3746931
OpenAlexW2042745675

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.